Our goal is to provide a clear, medically accurate comparison to help you make an informed choice alongside our professional healthcare team
A generic entry may be possible by 2026 if legal challenges succeed or patents expire earlier
Associated visual symptoms, papilledema, and pressure findings help distinguish IIH from migraine and other headache disorders
Serious hypersensitivity reactions, including anaphylaxis and angioedema have been reported with Wegovy LIMITATIONS OF USE According to the package insert, Wegovy should not be coadministered with other semaglutide-containing products or with any GLP-1 receptor agonist safety and efficacy in combination with other products intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established has not been studied in patient with a history of pancreatitis WARNINGS AND PRECAUTIONS The safety profile of semaglutide in the treatment of obesity has been investigated through several clinical trials
First 12 Weeks of Treatment As semaglutide begins slowing digestion and regulating appetite, your body goes through an adjustment phase